Search for: "Roche Holdings, Inc." Results 141 - 160 of 253
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Oct 2010, 5:51 pm by Michael C. Smith
  (In doing so, the Court was careful to note that it did not take into consideration the presence of the 4 court files from the related Echostarcase, "which would have remained in California but for that litigation" citing In re Hoffmann-La Roche Inc., 587 F.3d 1333,1337 (Fed. [read post]
18 Oct 2010, 2:01 pm by Raj Chohan
Hoffman La-Roche, Inc., 24 F.3d 463 (3d Cir. 1994), the Third Circuit Court of Appeals permitted the application of tolling to opt-in class actions arising under the Age Discrimination and Employment Act (“ADEA”). [read post]
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
7 Sep 2010, 6:10 pm by Kelly
Patent and Trademark Office et. al, (Prior Art) US: District Court New Jersey: Drug label may provide evidence of intent to induce infringement even though required by the FDA: Hoffmann-La Roche Inc. v. [read post]
2 Sep 2010, 2:07 pm by Mark Zamora
The makers of Accutane, Roche Holding AG, have been sued on multiple occassions over claims that the drug causes IBD.http://blogs.findlaw.com/decided/2010/08/105m-accutane-verdict-overturned.html [read post]
9 Aug 2010, 7:59 pm by Ed Wallis
Hoffmann LaRoche Inc., ATL- L-8213-05, New Jersey Superior Court, Atlantic County (Atlantic City). [read post]
6 Aug 2010, 9:10 am by Dr. Shezad Malik
"Roche Holding AG won reversal of a $10.5 million verdict over its Accutane [isotretinoin] acne drug because a judge improperly barred the company from using evidence about the medication's use," according to an appeals court ruling made in Kendall v. [read post]
29 Jul 2010, 6:48 pm
Hoffmann-La Roche, Ltd., 580 F.3d 1340, 1374 (Fed. [read post]
29 Jul 2010, 5:00 am by Bexis
Hoffmann-La Roche Inc., 892 A.2d 694, (N.J. [read post]
25 Jun 2010, 1:28 pm by Tom Lamb
We start with a June 24, 2010 Wall Street Journal article, "WellPoint's Data Led It To Limit Use Of Drug Boniva Article", from we learn that the largest U.S. managed care business in terms of membership, WellPoint Inc., has found through internal research that the osteoporosis drug Boniva, which is marketed by Roche Holding AG's Genentech and GlaxoSmithKline PLC, is linked to higher fracture rates than two other bisphosphonates, Actonel, marketed by… [read post]
22 Jun 2010, 12:41 pm by Erin Miller
Brief in opposition of respondents Independent Living Center of Southern California, Inc. et al. [read post]
21 Jun 2010, 9:57 am
Inc.), Merck Sharp & Dohme B.V. and Merck Sharp & Dohme is upon us. [read post]
6 May 2010, 4:12 pm by Bexis
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]